Genethon’s latest research, including advances in gene editing and AAV delivery vectors for gene therapy, to be featured at European Society for Gene and Cell Therapy, Oct. 11-14, 2022
“Our scientists will be presenting our most recent progress in novel therapeutic approaches, new vector development, genome editing strategies, improvement ...
